Hyperfine (HYPR) Total Current Liabilities (2020 - 2026)
Hyperfine's (HYPR) quarterly Total Current Liabilities came in at $10.2 million in Q1 2026, up 27.26% YoY from $8.0 million in Q1 2025, and down 13.45% on a QoQ basis from $11.7 million in Q4 2025.
Hyperfine (HYPR) Total Current Liabilities (2020 - 2026) Analysis & Trends
Hyperfine (HYPR) has 7 years of Total Current Liabilities data on file, last reported at $10.2 million in Q1 2026.
- Quarterly Total Current Liabilities rose 27.26% year-over-year to $10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.2 million (up 27.26% YoY) and the FY2025 annual result came in at $11.7 million, up 34.4% from the prior year.
- Total Current Liabilities eased to $10.2 million in Q1 2026, from $11.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $12.5 million in Q3 2022 to a low of $8.0 million in Q1 2025.
- A 5-year average of $9.4 million and a median of $8.8 million in 2024 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 9132.54% in 2022, down 44.06% in 2022.
- Tracing HYPR's Total Current Liabilities over 5 years: stood at $8.8 million in 2022, then decreased by 0.4% to $8.8 million in 2023, then slipped by 0.44% to $8.7 million in 2024, then surged by 34.4% to $11.7 million in 2025, then dropped by 13.45% to $10.2 million in 2026.
- The last three Total Current Liabilities figures came in at $10.2 million (Q1 2026), $11.7 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.61 Bn | 197.01 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 127.33 Bn | 123.85 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 119.23 Bn | 110.01 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 74.53 Bn | 73.99 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.84 Bn | 47.59 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 35.08 Bn | 33.14 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.86 Bn | 31.75 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.26 Bn | 22.94 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Hyperfine | 89.95 Mn | 45.18 Mn | 1.98 Mn | 9.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.63 Mn |
| Mar 31, 2026 | 10.15 Mn |
| Dec 31, 2025 | 11.73 Mn |
| Sep 30, 2025 | 10.17 Mn |
| Jun 30, 2025 | 7.99 Mn |
| Mar 31, 2025 | 7.98 Mn |
| Dec 31, 2024 | 8.73 Mn |
| Sep 30, 2024 | 9.96 Mn |
| Jun 30, 2024 | 8.79 Mn |
| Mar 31, 2024 | 8.77 Mn |
| Dec 31, 2023 | 8.77 Mn |
| Sep 30, 2023 | 8.21 Mn |
| Jun 30, 2023 | 8.04 Mn |
| Mar 31, 2023 | 8.00 Mn |
| Dec 31, 2022 | 8.80 Mn |
| Sep 30, 2022 | 12.46 Mn |
| Jun 30, 2022 | 10.46 Mn |
| Mar 31, 2022 | 11.41 Mn |
| Dec 31, 2021 | 15.74 Mn |
| Sep 30, 2021 | 1.95 Mn |